Recombinant Rhesus Macaque gp130/CD130/IL-6 R beta Protein (HEK293)，His

gp130, also known as CD130 or IL-6 receptor beta, is a crucial component of the interleukin-6 (IL-6) signaling pathway, which plays a significant role in the immune response, inflammation, and hematopoiesis. As a signal transducer, gp130 forms a functional receptor complex with IL-6 receptor (IL-6R) and initiates intracellular signaling cascades, primarily through the activation of Janus kinases (JAKs) and the subsequent phosphorylation of signal transducer and activator of transcription (STAT) proteins. Dysregulation of this pathway is implicated in various diseases, including autoimmune disorders, chronic inflammatory states, and malignancies. Recombinant forms of gp130 have been extensively studied for their potential therapeutic applications, including acting as competitive antagonists to inhibit IL-6 signaling in pathological conditions. Moreover, gp130 has emerged as a promising target for drug development due to its central role in modulating cytokine networks. Understanding the structure and function of recombinant gp130 is essential for elucidating its role in disease mechanisms and for optimizing therapeutic strategies. Researchers continue to investigate its interactions with other proteins and its influence on cellular responses, aiming to leverage this knowledge for innovative treatment approaches against a range of immune-related diseases.